57,851 results on '"Influenza, Human"'
Search Results
2. A Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above.
3. Comparative Immunogenicity of Concomitant vs Sequential mRNA COVID-19 and Influenza Vaccinations
4. Safety and Immunogenicity of Different Formulations of Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine With AS03 Adjuvant System in Medically Stable Adults
5. Intramuscular CodaVax-H1N1 in Healthy Adults
6. Household Influenza Transmission Study (HITS)
7. A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adults
8. DMID 21-0041; Influenza CVD 59000 (EMIT-2)
9. Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) in Participants 9 Through 49 Years of Age.
10. A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Quadrivalent Influenza Vaccine Compared to a Non-adjuvanted Quadrivalent Influenza Vaccine in Adults ≥65 Years of Age
11. A Study to Assess the Safety and Immune Response of Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) in Participants Aged 65 Years and Older in India
12. A Surveillance Study of Susceptibility to Baloxavir Marboxil in Participants With Influenza (Pebblestone)
13. A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months
14. Safety, Reactogenicity, and Immunogenicity Study of a Self-Amplifying mRNA Influenza Vaccine in Healthy Adults
15. Immunogenicity and Safety Study of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent
16. A Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months
17. Immunotherapy Combined With Radiation and Influenza Vaccine for Pancreatic Cancer. (INFLUENCE)
18. Screening for LID Clinical Studies Unit Healthy Volunteer Protocols
19. Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects
20. A Clinical Study to Evaluate an Experimental Universal Influenza Vaccine, INFLUENZA G1 mHA, in Healthy Adults
21. Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in Households
22. A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults
23. Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19) (PREDICT-ILI)
24. Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants From Birth to < 1 Year With Influenza-Like Symptoms
25. Influenza A (H7N9) Vaccine Delivered Intradermally by High-density Microarray Patch (HD-MAP) (HD-MAP)
26. Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults
27. Influenza Human Challenge Model
28. Comparison of Recombinant Influenza Vaccine Versus Standard Egg-Based Inactivated Influenza Vaccine in Adults 18-64 Years
29. Incentives for Influenza Vaccination
30. A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine
31. A Study to Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine (COVID-19)
32. Assess the Safety and Immunogenicity of One or Two Doses of Sing2016 M2SR H3N2 Influenza Vaccine
33. Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit
34. Substudy 01 - Safety and Immunogenicity of One Monovalent Modified mRNA Vaccine Encoding Influenza Hemagglutinin With LNP, in Adult Participants Aged 18 to 49 Years and 60 Years and Above
35. Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5413 in Adult Participants18 Years of Age and Older
36. Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults
37. Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza Vaccines
38. Age Related Differences in Respiratory Immune Responses in Influenza Virus Infection (NPA-DC)
39. High-risk Influenza Vaccine Alert
40. Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsE (ELIMINATE)
41. MGC Health COVID-19 & Flu A+B Home Multi Test Usability Study
42. Study of mRNA-1010 Seasonal Influenza Vaccine in Adults (IGNITE P303)
43. LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia
44. Study to Assess the Effect of Multistrain Probiotic on the Immune Response to the Influenza Vaccination (LUPIN)
45. LIAISON NES Influenza (FLU) A/B & Coronavirus Disease 2019 (COVID-19) Clinical Agreement in Australia
46. Project STARFISH - PRJ0002679 (STARFISH)
47. A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus
48. Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection
49. Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel
50. A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.